Filter
4670
Text search:
drug
policy
Featured
Recommendations
388
New Publications
1251
Language
Document type
No document type
2818
Studies & Reports
734
Guidelines
555
Manuals
201
Strategic & Response Plan
170
Fact sheets
59
Training Material
53
Situation Updates
47
Infographics
11
Resource Platforms
9
Brochures
5
Online Courses
5
App
2
Countries / Regions
India
219
Global
160
Kenya
156
Uganda
118
South Africa
117
Western and Central Europe
108
Nigeria
105
Ethiopia
104
Nepal
92
Liberia
80
Sierra Leone
79
Tanzania
79
Malawi
79
Zambia
77
Myanmar / Burma
73
Ghana
71
Africa
69
Latin America and the Carribbean
67
Bangladesh
63
Eastern Europe
59
Namibia
56
Ukraine
54
Rwanda
53
Asia
43
Zimbabwe
42
Philippines
36
South–East Asia Region
36
Cambodia
35
Lesotho
35
Russia
33
Indonesia
32
Botswana
28
Mozambique
22
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Senegal
19
Syria
19
Burkina Faso
18
East and Southern Africa
16
Brazil
15
West and Central Africa
13
Haiti
12
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Pakistan
11
South Sudan
11
Thailand
11
Eastern Europe and Central Asia
11
Guinea
10
Albania
10
Tajikistan
10
Georgia
10
Germany
9
Sudan
9
Vietnam
9
China
8
Afghanistan
7
Laos
7
Moldova
7
USA
6
Benin
6
North Macedonia
6
Sri Lanka
6
Yemen
6
Paraguay
6
Armenia
6
Peru
5
El Salvador
5
Mexico
5
Western Pacific Region
5
North America
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
Libya
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Bhutan
3
Palestine
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
Honduras
1
Greece
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1871
Clinical Guidelines
360
Public Health
228
Women & Child Health
169
Key Resources
138
Capacity Building
55
Pharmacy & Technologies
51
Toolboxes
HIV
622
TB
515
Mental Health
418
AMR
248
COVID-19
167
Pharmacy
137
NTDs
122
NCDs
90
Malaria
86
Caregiver
82
Planetary Health
66
Ebola & Marburg
57
Global Health Education
56
Disability
53
Refugee
51
Conflict
46
Rapid Response
45
Health Financing Toolbox
43
Polio
24
2.0 Rapid Response
23
Natural Hazards
15
Specific Hazards
13
Cholera
10
Social Ethics
10
Zika
7
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl
...
Human Rights Fact Sheet Series
Мы предлагаем вам ознакомиться с практическим руководством Программы Организации Объединенных Наций по международному контролю над наркотиками (ЮНДКП) по планир
...
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support the development and improvement of substance abuse treatment services, based on evidence from the litera
...
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large
...
Vol. 2: Clinicians' Guide
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
National AIDS and STI Control Program
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Comprehensive public health action on population ageing is urgently needed. This will require fundamental shifts, not just in the things we do, but in how we think about ageing itself. The World report on ageing and health outlines a framework for action to foster Healthy Ageing built around the new
...
Occasional anxiety is a normal part
of life. You might worry about things
like health, money, or family
problems. But people with
generalized anxiety disorder (GAD)
feel extremely worried or feel
nervous about these and other
things—even when there is little or
no reason to worry about the
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...